ArticleCancers2018

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Ashley M Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.